Value assessment of deprescribing interventions: Suggestions for improvement.

The article suggests improvements for the value assessment of deprescribing interventions to reduce potentially inappropriate medications. It outlines limitations to current practice of deprescribing cost-effectiveness analyses (CEA) and recommendations for improvement including application of longer time horizon for deprescribing CEAs, tailoring deprescribing CEAs to the needs of decision makers, and adding patient-centric value elements.